1037082-29-3

Basic information

• Product Name: tert-butyl (2-bromo-5-nitrobenzyl)(methyl)carbamate
• Synonyms: tert-butyl (2-bromo-5-nitrobenzyl)(methyl)carbamate
• CAS NO: 1037082-29-3
• Molecular Weight: 345.193
• Mol File: 1037082-29-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-butyl (2-bromo-5-nitrobenzyl)(methyl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (2-bromo-5-nitrobenzyl)(methyl)carbamate(1037082-29-3)
• EPA Substance Registry System: tert-butyl (2-bromo-5-nitrobenzyl)(methyl)carbamate(1037082-29-3)

Safety Data

• Hazardous Substances Data: 1037082-29-3(Hazardous Substances Data)

Upstream product

• 373622-95-8 2-bromo-N-methoxy-N-methyl-5-nitrobenzamide 
• 80887-01-0 2-bromo-5-nitrobenzoyl chloride 
• 943-14-6 2-bromo-5-nitrobenzoic acid 
• 6630-33-7 ortho-bromobenzaldehyde 
• 84459-32-5 2-bromo-5-nitrobenzaldehyde 
• 1037082-28-2 1-(2-bromo-5-nitrophenyl)-N-methylmethanamine 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant articles and documents

Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex

Inhibitors of the tissue factor (TF)/factor VIIa complex (TF-FVIIa) are promising novel anticoagulants which show excellent efficacy and minimal bleeding in preclinical models. Starting with an aminoisoquinoline P1-based macrocyclic inhibitor, optimizatio

PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS

The present invention relates to compounds that are useful as inhibitors of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer.